Natural selection of tumor variants in the generation of "tumor escape" phenotypes

被引:824
作者
Khong, HT [1 ]
Restifo, NP [1 ]
机构
[1] Natl Canc Inst, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1038/ni1102-999
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The idea that tumors must "escape" from immune recognition contains the implicit assumption that tumors can be destroyed by immune responses either spontaneously or as the result of immunotherapeutic intervention. Simply put, there is no need for tumor escape without immunological pressure. Here, we review evidence supporting the immune escape hypothesis and critically explore the mechanisms that may allow such escape to occur. We discuss the idea that the central engine for generating immunoresistant tumor cell variants is the genomic instability and dysregulation that is characteristic of the transformed genome. "Natural selection" of heterogeneous tumor cells results in the survival and proliferation of variants that happen to possess genetic and epigenetic traits that facilitate their growth and immune evasion. Tumor escape variants are likely to emerge after treatment with increasingly effective immunotherapies.
引用
收藏
页码:999 / 1005
页数:7
相关论文
共 105 条
[71]  
Ristimaki A, 1997, CANCER RES, V57, P1276
[72]   Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue [J].
Saito, H ;
Tsujitani, S ;
Ikeguchi, M ;
Maeta, M ;
Kaibara, N .
BRITISH JOURNAL OF CANCER, 1998, 78 (12) :1573-1577
[73]   Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance [J].
Sakaguchi, S ;
Sakaguchi, N ;
Shimizu, J ;
Yamazaki, S ;
Sakihama, T ;
Itoh, M ;
Kuniyasu, Y ;
Nomura, T ;
Toda, M ;
Takahashi, T .
IMMUNOLOGICAL REVIEWS, 2001, 182 :18-32
[74]  
SalazarOnfray F, 1997, J IMMUNOL, V159, P3195
[75]   Caspase activation: The induced-proximity model [J].
Salvesen, GS ;
Dixit, VM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (20) :10964-10967
[76]   MOLECULAR CHARACTERIZATION OF DEFECTIVE ANTIGEN-PROCESSING IN HUMAN PROSTATE-CANCER [J].
SANDA, MG ;
RESTIFO, NP ;
WALSH, JC ;
KAWAKAMI, Y ;
NELSON, WG ;
PARDOLL, DM ;
SIMONS, JW .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (04) :280-285
[77]  
SANO H, 1995, CANCER RES, V55, P3785
[78]   Immunodominance and tumor escape [J].
Schreiber, H ;
Wu, TH ;
Nachman, J ;
Kast, WM .
SEMINARS IN CANCER BIOLOGY, 2002, 12 (01) :25-31
[79]   A CELL-CULTURE MODEL FOR LYMPHOCYTE-T CLONAL ANERGY [J].
SCHWARTZ, RH .
SCIENCE, 1990, 248 (4961) :1349-1356
[80]  
Seliger B, 1997, EXP HEMATOL, V25, P608